Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Bayer reports K+ channel modulators for CNS disorders

May 10, 1996

5-HT reuptake inhibitors reported by HMR

May 10, 1996

Taisho discloses new series of sigma-receptor ligands

May 10, 1996

Santen reports sigma receptor ligands as potential psychopharmacologic drugs

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Hoechst claims bile acid sequestrants

May 10, 1996

Corydalin: ACAT inhibitor from natural source

May 10, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Bayer claimes quinolones and naphthyridines

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...